Literature DB >> 25038080

Calculated and perceived cardiovascular risk in asymptomatic subjects submitted to a routine medical evaluation: The perception gap.

Marcelo Katz1, Antonio G Laurinavicius2, Fabio G M Franco3, Raquel D Conceicao3, Jose A M Carvalho3, Antonio E P Pesaro3, Mauricio Wajngarten2, Raul D Santos2.   

Abstract

BACKGROUND: Poor adherence to medical treatment represents a major health problem. A subject's misperception of his own cardiovascular risk has been indicated as a key driver for low compliance with preventive measures. This study analysed the relationship between objectively calculated short- and long-term cardiovascular risk and its subjective perception.
DESIGN: Cross-sectional study in asymptomatic Brazilian subjects.
METHODS: Individuals (N = 6544, mean age 49.1 ± 7 years, 22.2% female) who underwent a routine mandatory health evaluation were studied. A questionnaire in which each individual rated his own cardiovascular risk as low, intermediate or high according to his own perception was used. The 10-year and lifetime cardiovascular risk were calculated respectively using the Framingham risk (FRS) and Lifetime risk (LRS) scores. Individuals were classified as hypo-perceivers (i.e. perceived risk lower than estimated risk), normo-perceivers (i.e. perceived risk coincident with estimated risk) and hyper-perceivers (i.e. perceived risk higher than estimated risk).
RESULTS: Cardiovascular risk, using the FRS, was low in 77.9% (N = 5071), intermediate in 14.4% (N = 939) and high in 7.7% (N = 499) of subjects. Cardiovascular risk, using the LRS, was low in 7.6% (N = 492), intermediate in 43.1% (N = 2787) and high in 49.3% (N = 3184) of the study population. The prevalence of normo-perceivers was 57.6% using the FRS and only 20.6% using the LRS. Using the LRS, 72.3% of the intermediate and 91.2% of the high-risk subjects were hypo-perceivers.
CONCLUSIONS: In a large sample of asymptomatic individuals, there was a gap between calculated and perceived cardiovascular risk. Using a long-term risk score, most of the intermediate- and high-risk subjects were hypo-perceivers. © The European Society of Cardiology 2014.

Keywords:  Cardiovascular disease; perception; risk

Mesh:

Year:  2014        PMID: 25038080     DOI: 10.1177/2047487314543074

Source DB:  PubMed          Journal:  Eur J Prev Cardiol        ISSN: 2047-4873            Impact factor:   7.804


  16 in total

1.  Low-density lipoprotein-cholesterol lowering in individuals at intermediate cardiovascular risk: Percent reduction or target level?

Authors:  Fernando H Y Cesena; Antonio Gabriele Laurinavicius; Viviane A Valente; Raquel D Conceição; Raul D Santos; Marcio S Bittencourt
Journal:  Clin Cardiol       Date:  2018-03-25       Impact factor: 2.882

2.  Association between clinical factors and self-underestimation of cardiovascular risk in subjects submitted to a routine health evaluation.

Authors:  Thais N Helou; Raul D Santos; Antonio G Laurinavicius; Marcio Sommer Bittencourt; Antonio E P Pesaro; Fabio G M Franco; Raquel D O Conceição; José A M Carvalho; Fernando M F Silva; Mauricio Wajngarten; Marcelo Katz
Journal:  Clin Cardiol       Date:  2018-01-22       Impact factor: 2.882

3.  Low Subjective Cardiovascular Disease Risk Perceptions among Hypertensive Patients in Addis Ababa, Ethiopia.

Authors:  Daniel Mengistu Bekele; Dejuma Yadeta Goshu; Alemayehu Worku Yalew; Melinda K Higgins; Rebecca A Gary
Journal:  Integr Blood Press Control       Date:  2022-08-05

4.  Cardiovascular risk perception in women: true unawareness or risk miscalculation?

Authors:  Miguel Cainzos-Achirica; Michael J Blaha
Journal:  BMC Med       Date:  2015-05-11       Impact factor: 8.775

5.  Behavioral cardiology: cardiology's new frontier of action.

Authors:  Marcelo Katz; Mauricio Wajngarten
Journal:  Arq Bras Cardiol       Date:  2015-01       Impact factor: 2.000

6.  Check-up and cardiovascular risk progression: is there a room for innovation?

Authors:  Raquel Dilguerian de Oliveira Conceição; Antonio Gabriele Laurinavicius; Nea Miwa Kashiwagi; José Antonio Maluf de Carvalho; Carlos Alberto Garcia Oliva; Raul Dias Santos Filho
Journal:  Einstein (Sao Paulo)       Date:  2015 Apr-Jun

7.  The Role of Family in a Dietary Risk Reduction Intervention for Cardiovascular Disease.

Authors:  Tracy L Schumacher; Tracy L Burrows; Deborah I Thompson; Robin Callister; Neil J Spratt; Clare E Collins
Journal:  Healthcare (Basel)       Date:  2016-09-30

8.  Suboptimal primary and secondary cardiovascular disease prevention in HIV-positive individuals on antiretroviral therapy.

Authors:  Rosan A van Zoest; Marc van der Valk; Ferdinand W Wit; Ilonca Vaartjes; Katherine W Kooij; Joppe W Hovius; Maria Prins; Peter Reiss
Journal:  Eur J Prev Cardiol       Date:  2017-06-05       Impact factor: 7.804

9.  The Expected Cardiovascular Benefit of Plasma Cholesterol Lowering with or Without LDL-C Targets in Healthy Individuals at Higher Cardiovascular Risk.

Authors:  Fernando Henpin Yue Cesena; Antonio Gabriele Laurinavicius; Viviane A Valente; Raquel D Conceição; Raul D Santos; Marcio S Bittencourt
Journal:  Arq Bras Cardiol       Date:  2017-06       Impact factor: 2.000

10.  Distribution of Short-Term and Lifetime Predicted Risks of Cardiovascular Diseases in Peruvian Adults.

Authors:  Renato Quispe; Juan Carlos Bazo-Alvarez; Melissa S Burroughs Peña; Julio A Poterico; Robert H Gilman; William Checkley; Antonio Bernabé-Ortiz; Mark D Huffman; J Jaime Miranda
Journal:  J Am Heart Assoc       Date:  2015-08-07       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.